The Acquisition Expands and Supports the Delivery of Integrated Behavioral Health Throughout the VA and Other Healthcare Partners
PHILADELPHIA, PA (PRWEB) JULY 18, 2023
NeuroFlow, the leading provider of behavioral health technology infrastructure, today announced that it has acquired Capital Solution Design (CSD), parent company to Behavioral Health Lab (BHL) and BHL Touch, a leading provider of measurement-based care solutions for the U.S. Department of Veterans Affairs (VA) and other healthcare organizations. The acquisition makes CSD a wholly-owned subsidiary, bringing BHL and BHL Touch and the company’s talent to NeuroFlow, reinforcing NeuroFlow’s best-in-class position as a technology enabler and infrastructure powering integrated behavioral healthcare at scale.
“BHL has an impressive reputation with their existing partners for enabling measurement-based care. This acquisition marks an exciting occasion in which our mutual partners are poised to benefit in a big way with more innovation and resources that are accomplished by bringing the organizations together,” said NeuroFlow Chief Executive Officer Chris Molaro. “We are eager to accelerate the implementation of BHL and BHL Touch at new facilities within the VA and to continue with various exciting collaborations and product developments already in progress.”
BHL and BHL Touch have been used by the VA for over fifteen years, providing workflow support to healthcare facilities and optimizing systems to better serve the clinical teams and individuals who need support through measurement-based care. With more than 150 public and private healthcare facilities as partners, BHL has collected over one million assessments in the last year alone. With the acquisition, NeuroFlow gains VA-specific Cerner and Vista electronic health record integration expertise for its technology, at a time when the VA is planning a years-long roll-out of the Cerner system at sites across the country. The BHL and BHL Touch platforms are also interoperable with Epic Systems.
“For over a decade BHL has helped develop and maintained the infrastructure needed to measure mental health outcomes and oversee the care for millions of Veterans across the entire VA network,” said Dr. Dave Oslin, Director of the VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC). “We’re looking forward to expanding the impact of BHL with NeuroFlow’s team, resources, and experiences, and ultimately have a broader and deeper impact to support more Veterans.”
The deal expands NeuroFlow’s operational footprint in the Washington, D.C. metropolitan area, and expands relationships in the federal government, Veterans space, and select academic medical centers.
“NeuroFlow’s commitment to innovation and their leadership’s vision for moving healthcare from reactive to proactive is what makes this a win-win for everyone, including Veterans who deserve the latest advancements in healthcare,” said CSD Co-Founder Kent Reynolds. “We’re proud of what we have accomplished with supporting healthcare with measurement-based care to date.” CSD Co-Founder John Boles added, “We could not be more excited for what is on the horizon with our mission and impact elevated in new ways. With the reach of NeuroFlow’s clients, supporting 15 million lives, and opening doors for greater access to screening, we’re going to help a lot of people.”
NeuroFlow provides the technology infrastructure that leading healthcare organizations need to deliver effective and scalable integrated programs that improve access to behavioral healthcare and lower costs. Powered by proof and clinical expertise, NeuroFlow’s next-generation software enables programs to bridge the gap between physical and mental health with proven solutions for psychiatric collaborative care, suicide prevention, and more. To learn more, visit https://www.neuroflow.com.
About Capital Solution Design and BHL/BHL Touch
Capital Solution Design is a leading provider of measurement-based care (MBC) solutions for the Department of Veterans Affairs (VA). CSD’s solutions help clinicians to measure and track patient progress, identify areas of need, and adjust treatment plans accordingly. CSD is headquartered in the Washington, D.C. metropolitan area and is the parent company of BHL and BHL Touch.